Virbac SA (VIRP.PA)
- Previous Close
305.50 - Open
305.00 - Bid --
- Ask --
- Day's Range
304.50 - 310.00 - 52 Week Range
249.70 - 400.00 - Volume
6,639 - Avg. Volume
5,214 - Market Cap (intraday)
2.61B - Beta (5Y Monthly) 0.84
- PE Ratio (TTM)
17.95 - EPS (TTM)
17.35 - Earnings Date May 13, 2025
- Forward Dividend & Yield 1.45 (0.47%)
- Ex-Dividend Date Jun 24, 2025
- 1y Target Est
386.83
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
corporate.virbac.com6,365
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: VIRP.PA
View MorePerformance Overview: VIRP.PA
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VIRP.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VIRP.PA
View MoreValuation Measures
Market Cap
2.61B
Enterprise Value
2.77B
Trailing P/E
17.96
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.87
Price/Book (mrq)
2.50
Enterprise Value/Revenue
1.98
Enterprise Value/EBITDA
10.02
Financial Highlights
Profitability and Income Statement
Profit Margin
10.40%
Return on Assets (ttm)
8.66%
Return on Equity (ttm)
14.93%
Revenue (ttm)
1.4B
Net Income Avi to Common (ttm)
145.29M
Diluted EPS (ttm)
17.35
Balance Sheet and Cash Flow
Total Cash (mrq)
153.91M
Total Debt/Equity (mrq)
29.98%
Levered Free Cash Flow (ttm)
70.46M